ArticleCureus2026
Heart Rate Variability and Cognitive Function as Potential Endophenotypes in Schizophrenia: A Cross-Sectional Observational Study Using First-Degree Relatives.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Heart rate variability (HRV) represents beat-to-beat fluctuations in heart rate arising from the dynamic balance between sympathetic and parasympathetic nervous system activity. Altered HRV reflects autonomic dysregulation and has been reported across several psychiatric disorders, including schizophrenia, where it may contribute to cardiovascular risk and cognitive dysfunction. Aim The aim of this study was to compare the time-domain and frequency-domain heart rate variability parameters between patients with schizophrenia and their first-degree relatives and to analyze the correlation between heart rate variability indices and cognitive performance within an endophenotypic framework. Methods This healthcare-based cross-sectional observational study was performed at the Kalinga Institute of Medical Sciences in Bhubaneswar, India, from October 2023 to October 2024. Fifteen clinically stable subjects diagnosed with schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria and fifteen age- and gender-matched first-degree relatives without schizophrenia were included. 5-minute resting HRV was assessed once at a single time point using a standardized three-lead electrocardiogram (ECG) after a 10-minute adaptation period. Time-domain parameters measured overall variability, whereas frequency-domain parameters analyzed sympathetic and parasympathetic modulation. Cognitive functioning was assessed using the Wechsler Abbreviated Scale of Intelligence (WASI). To compare the groups, we used the Mann-Whitney U test, and to look for associations, we used Spearman's rank correlation. Results Time-domain heart rate variability parameters were comparable between patients with schizophrenia and first-degree relatives (p > 0.05). In the frequency domain, the low frequency (LF) to high frequency (HF) ratio (LF/HF) was significantly higher in patients with schizophrenia than in their relatives (median 1.57 vs. 0.79; p = 0.041), indicating relative sympathetic predominance. Absolute LF, HF, and very-low-frequency (VLF) power values did not differ significantly between groups (p > 0.05). Within the schizophrenia group, the LF/HF ratio showed a significant positive correlation with WASI scores (r = 0.701, p = 0.004). Conclusion Schizophrenia is associated with altered autonomic regulation characterized by an increased LF/HF ratio, suggesting sympathovagal imbalance, while time-domain HRV measures remain comparable to those of first-degree relatives. The observed association between autonomic modulation and cognitive performance supports the relevance of HRV as a potential physiological marker linked to cognitive functioning in schizophrenia. Further longitudinal and genetic studies are required to clarify its role as a potential endophenotypic trait.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.